Compugen Stock

Compugen Tax Expense

Delisted·Jun 15, 2026

The Income Tax Expense of Compugen (CGEN) as of Aug 3, 2026 is 54,000.00 USD. In the previous year, Income Tax Expense was 4.52 M USD — a change of -98.81% (lower).

Tax Expense

54,000.00USD

YoY

-98.81%

Last updated:

Income Tax Expense of Compugen is 2026 54,000.00 USD. Income Tax Expense of Compugen was 2025 4.52 M USD. It decreases by -98.81% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Income Tax Expense of Compugen is 54,000.00 USD in 2026.

Income Tax Expense of Compugen changed from 4.52 M USD to 54,000.00 USD, representing a -98.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense Compugen since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Compugen historically and in real time.

Access this data via the Eulerpool API

Income Statement — Compugen

All Key Metrics — Compugen